Newsroom Inflammatix in the news Inflammatix Checks off All the Right Boxes with Investors Mar 19, 2021 Inflammatix nets $102M to advance its immune system tests for infectious diseases Mar 16, 2021 Infection-detection system from Peninsula company scores $102M, aims to hit market this year Mar 16, 2021 A Bright Future Ahead for Novel Markers of Infection Dec 15, 2020 Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test Oct 29, 2020 Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform Oct 8, 2020 Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk Sep 30, 2020 Three Predictions For Healthcare Platforms Sep 8, 2020 20 medical device startups you need to know Jun 26, 2020 MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator Jun 22, 2020 The Battle for a Better Sepsis Test Apr 1, 2020 Stanford alumni founders tackle COVID-19 with StartX task force Mar 19, 2020 Older NewsRecent News Inflammatix collects $57M as it awaits FDA review of infectious disease test Sep 12, 2024 Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million Sep 12, 2024 Rapid Tests Continue Push Into Sepsis Market in 2023 as Competition Heats Up Jan 2, 2024 Older NewsRecent News Inflammatix sepsis test scores FDA breakthrough device designation Nov 28, 2023 Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test Nov 28, 2023 Your medical devices are getting smarter. Can the FDA keep them safe? Oct 9, 2023 Point-of-care testing for infectious diseases in emergency settings Jan 18, 2023 Do Your Genes Know What’s Making You Sick? Jan 6, 2022 Artificial Intelligence for Clinical Decision Support in Sepsis May 13, 2021 Older NewsRecent News Press releases Nov 15, 2023 Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System Sep 13, 2023 UMCG and Inflammatix Collaborate to Improve Early Recognition and Clinical Decision Support for Sepsis Care Jul 10, 2023 Inflammatix Appoints Heiner Dreismann as New Board Member Jun 15, 2022 Inflammatix Appoints Dr. Purvesh Khatri as Chief Scientific Officer Nov 30, 2021 Inflammatix Appoints Dr. Kian Beyzavi as New Board Member Nov 18, 2021 Inflammatix Announces Additional $12.1 Million Funding from BARDA for ViraBac EZ Acute Infection Test Older Press ReleasesRecent Press Releases Machine learning blogs Podcasts Diagnosing Infection with Ljubomir Buturovic from Inflammatix December 2023 Advances in Sepsis Diagnostics: the HostDx Sepsis Platform May 2018 Media Contact [email protected]
Infection-detection system from Peninsula company scores $102M, aims to hit market this year Mar 16, 2021
Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test Oct 29, 2020
Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform Oct 8, 2020
Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk Sep 30, 2020
MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator Jun 22, 2020
Targeting FDA OK for its test against deadly sepsis, South Bay company raises $57 million Sep 12, 2024
Nov 15, 2023 Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System
Sep 13, 2023 UMCG and Inflammatix Collaborate to Improve Early Recognition and Clinical Decision Support for Sepsis Care
Nov 18, 2021 Inflammatix Announces Additional $12.1 Million Funding from BARDA for ViraBac EZ Acute Infection Test
